PDF

Cover and Contents

PDF

An update comprehensive review on the status of COVID-19: vaccines, drugs, variants and neurological symptoms
EBRU ÖZKAN OKTAY, SALİH TUNCAY, TUĞBA KAMAN, ÖMER FARUK KARASAKAL, ÖZNUR ÖZGE ÖZCAN, TUĞÇE SOYLAMIŞ, MESUT KARAHAN, and MUHSİN KONUK
Pages 342-357

PDF

Novel approaches for COVID-19 diagnosis and treatment: A Nonsystematic Review
ŞEBNEM GARİP USTAOĞLU, HAKAN KAYGUSUZ, MEHMET DİNÇER BİLGİN, and FERİDE SEVERCAN
Pages 358-371

PDF

Pathogenesis and Treatment of Cytokine Storm in COVID-19
MEHMET SOY, GÖKHAN KESER, and MEHMET PAMİR ATAGÜNDÜZ
Pages 372-389

PDF

Neuropathy in COVID-19 associated with dysbiosis-related inflammation
BUSRA AKTAS and BELMA ASLIM
Pages 390-403

PDF

Host Variations in SARS-CoV-2 Infection
DORUK ALTIOK, ELİF ZEYNEP SAVCI, BÜŞRA ÖZKARA, KAMİL ALKAN, DİLARA SULTAN NAMDAR, GİZEM TUNÇER, BUĞRAHAN REGAİP KILINÇ, EVREN SUİÇMEZ, GÜNEYSU ÇETİN, SİNAN ÜNAL, BEYZA DÖNMÜŞ, ZEYNEP YAĞMUR KARAGÜLLEOĞLU, DİLRÜBA BEYZA UNCUOĞLU, CANSU TEKELİ, and HANİFE AYŞEGÜL MENDİ
Pages 404-424

PDF

Genomic Chronicle Of SARS-COV-2: A Mutational Analysis with Over 1 million Genome Sequences
OSMAN MUTLUHAN UĞUREL, OĞUZ ATA, and DİLEK BALIK
Pages 425-435

PDF

The effect of weekend curfews on epidemics: a Monte Carlo simulation
HAKAN KAYGUSUZ and AHMET NİHAT BERKER
Pages 436-441

PDF

In silico drug repositioning against human NRP1 to block SARS-CoV-2 host entry
ŞEREF GÜL
Pages 442-458

PDF

Binary-QSAR guided virtual screening of FDA approved drugs and compounds in clinical investigation against SARS-CoV-2 main protease
LALEHAN OKTAY, ECE ERDEMOĞLU, İLAYDA TOLU, YEŞİM YUMAK, AYŞENUR ÖZCAN, ELİF ACAR, ŞEHRİBAN BÜYÜKKILIÇ, ALPSU OLKAN, and SERDAR DURDAĞI
Pages 459-468

PDF

The current state of validated small molecules inhibiting SARS-CoV-2 non-structural proteins
FATİH KOCABAŞ and MERVE USLU
Pages 469-483

PDF

Determination of the interaction between the receptor binding domain of 2019-nCoV spike protein, TMPRSS2, cathepsin B and cathepsin L and glycosidic and aglycon forms of some flavonols
ERMAN SALİH İSTİFLİ, ARZUHAN ŞIHOĞLU TEPE, PAULO AUGUSTO NETZ, CENGİZ SARIKÜRKCÜ, İBRAHİM HALİL KILIÇ, and BEKTAŞ TEPE
Pages 484-502

PDF

ß-Carboline alkaloids induce structural plasticity and inhibition of SARS-CoV-2 nsp3 macrodomain more potently than remdesivir metabolite GS-441524: Computational approach
YUSUF OLORUNTOYIN AYIPO, SANI NAJIB YAHAYA, HALIMAH FUNMILAYO BABAMALE, IQRAR AHMAD, HARUN PATEL, and MOHD NIZAM MORDI
Pages 503-517

PDF

Treatment of COVID-19 Patients with Quercetin in Combination with Vitamin C and Bromelain: A Prospective, Single - Centre, Randomized, Controlled Trial
HASAN ÖNAL, BENGÜ ARSLAN, NURCAN ÜÇÜNCÜ ERGUN, HANİM ŞEYMA TOPUZ, SEDA YILMAZ SEMERCİ, MEHMET EREN KURNAZ, YULET MİRAY MOLU, MEHMET ABDUSSAMET BOZKURT, NURETTİN SÜNER, and ALİ KOCATAŞ
Pages 518-529

PDF

Targeting CoV-2 Spike RBD and ACE-2 Interaction with Flavonoids of Anatolian Propolis by in silico and in vitro Studies in Terms of Possible COVID-19 Therapeutics
HALİL İBRAHİM GÜLER, FULYA AY ŞAL, ZEHRA CAN, YAKUP KARA, OKTAY YILDIZ, ALİ OSMAN BELDÜZ, SABRİYE ÇANAKÇI, and SEVGİ KOLAYLI
Pages 530-548

PDF

CoronaVac (Sinovac) COVID-19 vaccine-induced molecular changes in healthy human serum by infrared spectroscopy coupled with chemometrics
AYÇA DOĞAN MOLLAOĞLU, RAFİG GURBANOV, METE SEVERCAN, and FERİDE SEVERCAN
Pages 549-558

PDF

The potential use of Drosophila as an in vivo model organism for COVID-19-related research: A review
EŞREF DEMİR
Pages 559-569

PDF

Cannabinoids for SARS-CoV-2 and is there evidence of their therapeutic efficacy?
AHMET ONAY, ABDULSELAM ERTAŞ, VEYSEL SÜZERER, İSMAİL YENER, MUSTAFA ABDULLAH YILMAZ, EMİNE AYAZ TİLKAT, REMZİ EKİNCİ, NESRİN BOZHAN, and SEVGİ İRTEGÜN
Pages 570-587